AI Analysis AI Analysis of CRMD AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRMD to Watchlist?
Some Reasons Why To Add CRMD:
  • Beat earnings estimates in all of the last 4 quarters
  • High gross margin of 85.8%
  • Strong operating margin of 48.4%
PDF

Evaluation of CorMedix Inc stock downgraded after the last trading session
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Loss -0.95%

The CorMedix Inc stock price fell by -0.95% on the last day (Monday, 13th Jul 2026) from $8.40 to $8.32. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 2.31% from a day low at $8.22 to a day high of $8.41. The price has been going up and down for this period, and there has been a 5.99% gain for the last 2 weeks. Volume has increased on the last day by 98 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 875 thousand shares were bought and sold for approximately $7.28 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.90% during the next 3 months and, with a 90% probability hold a price between $9.17 and $10.99 at the end of this 3-month period.

CRMD Signals & Forecast

There are few to no technical positive signals at the moment. The CorMedix Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $8.66 and $8.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -6.20%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for CorMedix Inc stock

CorMedix Inc finds support from accumulated volume at $7.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.190 between high and low, or 2.31%. For the last week, the stock has had daily average volatility of 3.57%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRMD) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect CorMedix Inc to open at $8.32, and during the day (based on 14 day Average True Range), to move between $8.14 and $8.50, which gives a possible trading interval of +/-$0.358 (+/-4.39%) up or down from last closing price. If CorMedix Inc takes out the full calculated possible swing range there will be an estimated 4.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.54 (2.64%) than the support at $7.93 (4.69%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CorMedix Inc stock A Buy?

The CorMedix Inc stock holds several negative signals and despite the positive trend, we believe CorMedix Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.028 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $8.32 ( 0.0405%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRMD Performance

Trading levels for CRMD

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.51 2.24%
R2 8.43 1.37%
R1 8.39 0.83%
Price 8.32
S1 8.24 -0.91%
S2 8.20 -1.45%
S3 8.13 -2.32%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.82 6.01%
R2 8.67 4.21%
R1 8.54 2.64%
Price 8.32
S1 7.93 -4.69%
S2 7.82 -6.01%
S3 7.72 -7.21%

FAQ

What is the symbol for CorMedix Inc Stock and on which exchange is it traded?
The symbol for CorMedix Inc is CRMD and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell CorMedix Inc Stock?
The CorMedix Inc stock holds several negative signals and despite the positive trend, we believe CorMedix Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy CorMedix Inc Stock?
CorMedix Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CorMedix Inc Stock.

What's the current price of CorMedix Inc Stock?
As of the end of day on the Jul 13, 2026, the price of an CorMedix Inc (CRMD) share was $8.32.

What is the 52-week high and low for CorMedix Inc Stock?
The 52-week high for CorMedix Inc Stock is $14.96 and the 52-week low is $6.13.

What is the market capitalization of CorMedix Inc Stock?
As of the Jul 13, 2026, the market capitalization of CorMedix Inc is 652.72M.

When is the next earnings date for CorMedix Inc?
The upcoming earnings date for CorMedix Inc is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CORMEDIX INC
CorMedix
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical setting...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE